This page contains answers to frequently asked questions regarding filing an opioid lawsuit behalf of newborns and children suffering from the aftereffects of fetal exposure to opioids. Our team of lawyers handling opioid lawsuit claims provides free, no obligation case review. To discuss your case in detail or discuss your situation with any attorney handling opioid lawsuit claims, contact our firm. One of our experienced lawyers for national opioid lawsuit claims for neonatal abstinence syndrome will contact you in the near future to answer your questions, completely free of charge.

Is there a fee to have an attorney review my case?

We will always listen to your circumstances and give you our analysis of your case without any cost or further obligation.

Are there opioid lawsuit time limits that may apply to my case?

Most states do have opioid lawsuit time limits; however, the majority of all with a claim related to an opioid addicted baby will fall within those time limits if they contact an attorney in the near future. For specific time limits for your claim, please fill out our form and one of our attorneys will contact you as quickly as possible, usually within the hour.

What does it cost to file an opioid lawsuit on behalf of a child born with opioid withdrawal?

We are committed to representing all persons involved in an opioid lawsuit on a contingency basis, meaning there are never any legal fees unless we win compensation in your case. To access your free, no-obligation consultation, use the online chat feature or contact form on this site. One of our lawyers handling opioid lawsuits for babies exposed to opioids before birth will contact you to answer any of your questions.

Who is eligible to make an opioid claim or file a Neonatal Abstinence Syndrome lawsuit?

If a child in your family was born with a dependence on opioid drugs or was diagnosed with Neonatal Abstinence Syndrome, your family may be eligible to make a claim by filing an opioid lawsuit against pharmaceutical manufacturers. The effects of infant opioid addiction stretch well into childhood and can significantly hamper the growth and development of a child.

We’re not the type of people who sue; do we really need to file a lawsuit?

If a member of your family suffered a serious injury or health problem as a result of a defective product or dangerous drug, long-term, or even lifelong, medical care may be required. This could be incredibly expensive and since medical costs are continually rising may be largely unknown at the time of settlement or trial. If a member of your family died due to a defective product or dangerous drug, no amount of money can undo that wrong. It is our fervent hope that every defective products, drug or other medication lawsuit we file can serve to make the manufacturer take note of the loss and pain its product has caused. When that fails to make a company take action in the form of a product recall, greater warnings about its use and ultimately making safer products, we rely on their profit motivation to make them do the right thing. Unfortunately, in all too many cases it is only the fear of lawsuits and large settlements and verdicts that makes a company become a better corporate citizen.

Who is at risk for Neonatal Abstinence Syndrome?

Babies born with opioid dependence were exposed to the highly-addictive substance because the mother took one or more opioid drugs during pregnancy. The degree of severity depends on the baby stage of gestation at birth, as well as which opioid the mother took and how recently before the infant’s birth. How long the effects of opioid dependence will affect a child are difficult to predict with the limited information we have on this condition.

Aren’t most drug and products liability lawsuits just class action lawsuits where the plaintiff receives very little money?

National opioid lawsuit claims have already been consolidated as MDL, or Multi-District Litigation, where each plaintiff receives a settlement based upon the individual injuries and damages incurred by each plaintiff. This process increases the efficiency of handling similar cases filed against one or more companies, in this case all related to opioid drugs resulting in harm to fetuses.